pancreatic cancer and semaglutide Your pancreas may be making its own version of Ozempic Pancreatic cancer: GLP-1 drugs such

Yip RG-C, Boylan MO, Kieffer TJ, et al

As we age, our natural production of glutathione, the body's master antioxidant, declines, leaving us more vulnerable to fatigue, toxins, and oxidative stress.* But you can fight back

In a 4-year CV outcomes trial (Trial 7), 4,825 patients were randomized to semaglutide tablets for a median follow-up of 49.6 months and 4,825 patients were randomized to placebo for a median follow-up of 49.4 months [see Clinical Studies (14.4)]

However, the picture is far from unambiguously positive

Yet, practicing physicians have been largely overlooked

Colt Clemons Feb 2210 min read bottom of page